IL17A and rheumatoid arthritis: Blockade of IL-17 has previously been shown to ameliorate experimental arthritis and is also a promising therapeutic avenue in RA (Lubberts et al., 2001, , 2004; Pöllinger et al., 2011; van den Berg and McInnes, 2013).